Nikita Shah

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Ingrid A. Mayer, Linda T. Vahdat et al. · New England Journal of Medicine · 2019 · 850 citations

Medicine, Oncology, Pharmacology +17

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Ingrid A. Mayer, Jennifer R. Diamond et al. · Journal of Clinical Oncology · 2017 · 409 citations

Medicine, Oncology, Pharmacology +12

Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings

Fernando J. Martínez, MeiLan K. Han, Camden Lopez et al. · JAMA · 2023 · 54 citations · Full text

Medicine, Health Informatics, Pulmonary Function Testing +8

LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

Amanda E.D. Van Swearingen, Marni B. Siegel, Allison M. Deal et al. · Breast Cancer Research and Treatment · 2018 · 48 citations · Full text

Medicine, Oncology, Pharmacology +14

Patterns of Progression in Metastatic Estrogen Receptor Positive Breast Cancer: An Argument for Local Therapy

Patrick Kelly, Zhe Ma, Said Baidas et al. · International Journal of Breast Cancer · 2017 · 27 citations · Full text

Medicine, Endocrinology, Oncology +17